SEC Form 4 · accession 0001127602-16-054697

Elevance Health, Inc. · ELV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP & Chief Administrative Off

Period of report

Jun 1, 2016

Accepted (ET)

Jun 3, 2016 · 4:09 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001156039

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jun 1, 2016	M	2,031	$77.50	A	48,326	D
Common Stock	Jun 1, 2016	M	2,755	$89.44	A	51,081	D
Common Stock^F2	Jun 1, 2016	S	4,786	$131.69	D	46,295	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F3	$77.50	Jun 1, 2016	M	2,031	D	—	Jun 3, 2020	Common Stock	2,031	927	D
Employee Stock Option (Right to Buy)^F4	$89.44	Jun 1, 2016	M	2,755	D	—	Mar 3, 2021	Common Stock	2,755	22,916	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2016.
F2This transaction was executed in multiple trades at prices ranging from $131.18 to $132.07. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3The option, representing a right to purchase a total of 5,562 shares, became exercisable in six semi-annual installments of 927 shares each beginning on December 3, 2013, which was the six-month anniversary of the date on which the option was granted.
F4The option, representing a right to purchase a total of 25,671 shares, became exercisable in three semi-annual installments of 4,278 shares each and three semi-annual installments of 4,279 shares each beginning on September 3, 2014, which was the six-month anniversary of the date on which the option was granted.